Last $8.08 USD
Change Today +0.53 / 7.02%
Volume 793.4K
XNPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William J. Rieflin

Consultant and Director, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 30 board members in 3 different organizations across 3 different industries.

See Board Relationships
54$136,983

Background*

Mr. William J. Rieflin, also known as Bill, has been the Chief Executive Officer of NGM Biopharmaceuticals, Inc. since October 5, 2010. Mr. Rieflin has been a Consultant of Xenoport, Inc., since September 17, 2010. He served as the President of Xenoport Inc. since September 2004 and oversees its corporate development, human resources, legal and administrative functions. He served as Strategic Advisor at NGM Biopharmaceuticals, Inc. until October 5, 2010. He served as ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

2010-Present
Consultant and Director
2010-Present
Chief Executive Officer and Director
2011-Present
Independent Lead Director, Chairman of Audit Committee and Member of Compensation Committee

Education*

BS
Cornell University
MBA
The University of Chicago Booth School of Business
JD
Stanford University Law school

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$45,000
Total Calculated Compensation$136,983
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $8.08 USD +0.53

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
--
Scott Schorer Chief Executive Officer
PlasmaTech Biopharmaceuticals, Inc.
--
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
Arun Suresh Chandavarkar B.Tech., M.S., Ph.D.(Chemical Eng.)Chief Executive Officer, Joint Managing Director and Additional Director
Biocon Limited
--
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.